BioNTech has officially completed the acquisition of InstaDeep Ltd.—a technology company in the artificial intelligence (AI) and machine learning (ML) space— for approximately $549 million.  The takeover follows a collaboration between the two parties since 2019 and an equity...

Biogen agreed to give $172.50 per share in cash to Reata, accompanied by term debt issuance. The transaction will close in the fourth quarter of 2023. Biogen’s president and chief executive officer, Christopher Viehbacher, said the company believes it has the foundation in place to...

    Regenerative medicine company, Carmell Therapeutics, announced the execution of a definitive agreement and plan of merger (the “Merger Agreement”) with Flagstaff-based Axolotl Biologix. Axolotl develops, designs, and sells products that are human amnion-based, for...

    Quince Therapeutics (Nasdaq: QNCX) in its agreement to acquire EryDel SpA in a stock-for-stock upfront exchange and potential downstream milestone cash payments. Quince Therapeutics is a biotechnology company focused on acquiring, developing, and commercializing...